Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.

Abstract excerpt

INTRODUCTION: Mutations in genes associated with splicing have been found in hematologic malignancies, but also in solid cancers. Aberrant cancer specific RNA splicing either results from mutations or misexpression of the spliceosome genes directly, or from mutations in splice sites of oncogenes or tumor suppressors. Areas covered: In this review, we present molecular targets of aberrant splicing in various...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alternative Splicing
• Share to Antineoplastic Agents
• Share to Molecular Targeted Therapy